Chesapeake Urology Associates Launches Prostate Cancer Website
BALTIMORE, April 2, 2013 /PRNewswire/ -- Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, has launched a comprehensive website devoted strictly to its Prostate Cancer Care Program.
The site, with a URL of http://prostatecancer.chesapeakeurology.com, is an easy-to-access body of information that was built for prostate cancer patients and consumers alike. It provides detail on how prostate cancer is diagnosed, treatment options for different stages of the disease, answers to frequently asked questions, a glossary of terms and recommended questions to ask at a physician appointment. This informational source gives patients more detail and perspective about prostate cancer, and enables them to select the treatment pathway that is right for them.
In addition, the site outlines the Chesapeake Urology Prostate Cancer Care Program, including its mission, experts, clinical trials, support networks and patient resources. There are also patient stories, blogs and information about the Zero Prostate Cancer Challenge, which features a 5K run, a 1 mile walk and free prostate cancer screenings held each September during National Prostate Cancer Awareness Month.
"The new website serves as an informational tool to help people learn more about prostate cancer and the high level of care provided by Chesapeake Urology physicians and staff," says Benjamin Lowentritt, M.D., director of Chesapeake Urology's Prostate Cancer Care program. "It also demonstrates Chesapeake Urology's leadership, experience and commitment to the fight against prostate cancer."According to Dr. Lowentritt, 1 in every 6 men will get prostate cancer sometime in his life. About 241,740 new cases of prostate cancer were diagnosed in 2012 - on par with breast cancer. In addition, the chances of getting prostate cancer are 1 in 3 if you have just one close relative (father, brother) with the disease. The risk is 83 percent with two close relatives and 97 percent with three.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts